Cite
Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study.
MLA
Jorge Calles-Escandón, et al. “Glucose Sensor-Augmented Continuous Subcutaneous Insulin Infusion in Patients with Diabetic Gastroparesis: An Open-Label Pilot Prospective Study.” PLoS ONE, vol. 13, no. 4, Jan. 2018, p. e0194759. EBSCOhost, https://doi.org/10.1371/journal.pone.0194759.
APA
Jorge Calles-Escandón, Kenneth L Koch, William L Hasler, Mark L Van Natta, Pankaj J Pasricha, James Tonascia, Henry P Parkman, Frank Hamilton, William H Herman, Marina Basina, Bruce Buckingham, Karen Earle, Kjersti Kirkeby, Kristen Hairston, Tamis Bright, Amy E Rothberg, Andrew T Kraftson, Elias S Siraj, Angela Subauste, … NIDDK Gastroparesis Clinical Research Consortium (GpCRC). (2018). Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study. PLoS ONE, 13(4), e0194759. https://doi.org/10.1371/journal.pone.0194759
Chicago
Jorge Calles-Escandón, Kenneth L Koch, William L Hasler, Mark L Van Natta, Pankaj J Pasricha, James Tonascia, Henry P Parkman, et al. 2018. “Glucose Sensor-Augmented Continuous Subcutaneous Insulin Infusion in Patients with Diabetic Gastroparesis: An Open-Label Pilot Prospective Study.” PLoS ONE 13 (4): e0194759. doi:10.1371/journal.pone.0194759.